Today, a brief rundown of news from PTC Therapeutics, Esperion Therapeutics and Coherus Biosciences, as well as updates from Sanofi, Lantheus Holdings and Forbion that you may have missed.
Drug regulators in Europe have, for a third time, recommended against renewing the approval of PTC…
[ad_2]
Source link
